Share 'Reversal of type 1 diabetes via islet β cell regeneration'
Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells Research abstract published in BMC Medicine Background Inability to control autoimmunity is the primary barrier to developing a cure for type 1 diabetes (T1D). Evidence that human cord blood-derived multipotent stem cells (CB-SCs) can control autoimmune responses by a…
You can share this discussion in two ways…
© 2013 A community of people touched by diabetes, run by the Diabetes Hands Foundation.
